Burden of Hospitalizations Due to Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) in Patients Who Failed First Line Rituximab or Rituximab Plus Chemotherapy Following Solid Organ Transplant (Post-SOT)
A Retrospective Chart Review Study of German PTLD Registry
Vortragender: PD Dr. Heiner Zimmermann beim 61. ASH 2019